Nuvo Pharmaceuticals Inc (MRVFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,951 | 22,382 | 20,960 | 24,634 | 22,569 |
| Receivables | 7,702 | 7,604 | 7,618 | 5,206 | 6,718 |
| Inventories | 6,392 | 7,436 | 7,248 | 6,809 | 6,849 |
| Other current assets | 1,665 | 1,951 | 3,617 | 3,802 | 3,618 |
| TOTAL | $39,709 | $39,372 | $39,443 | $40,452 | $39,753 |
| Non-Current Assets | |||||
| PPE Net | 2,234 | 2,340 | 2,423 | 2,539 | 2,545 |
| Intangibles | 54,917 | 56,126 | 58,006 | 60,264 | 64,111 |
| Other Non-Current Assets | 645 | 676 | 704 | 735 | 867 |
| TOTAL | $57,797 | $59,142 | $61,133 | $63,538 | $67,522 |
| Total Assets | $97,506 | $98,514 | $100,576 | $103,990 | $107,276 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,947 | 9,556 | 9,346 | 9,846 | 9,586 |
| Accounts payable and accrued liabilities | 7,975 | 8,186 | 9,954 | 9,168 | 7,346 |
| Other current liabilities | 200 | 233 | 1,199 | 1,085 | 1,169 |
| TOTAL | $18,838 | $18,139 | $20,542 | $20,099 | $18,180 |
| Non-Current Liabilities | |||||
| Long Term Debt | 64,796 | 63,650 | 63,583 | 66,521 | 68,174 |
| Other Non-Current Liabilities | 3,402 | 6,176 | 21,277 | 24,305 | 23,747 |
| TOTAL | $72,167 | $73,484 | $87,196 | $92,981 | $93,795 |
| Total Liabilities | $91,005 | $91,623 | $107,738 | $113,080 | $111,975 |
| Shareholders' Equity | |||||
| Common Shares | 141,566 | 144,689 | 145,890 | 147,423 | 146,777 |
| Retained earnings | -147,137 | -150,733 | -166,419 | -169,791 | -164,603 |
| Other shareholders' equity | -572 | 35 | 355 | 206 | 149 |
| TOTAL | $6,501 | $6,891 | $-7,162 | $-9,091 | $-4,699 |
| Total Liabilities And Equity | $97,506 | $98,514 | $100,576 | $103,990 | $107,276 |